Utility of Platelet-Rich Plasma and Growth Factors Bone in the Bone Defects
We present the results obtained with the use of platelet-rich plasma and a hydroxyapatite and bovine collagen graft in the management of bone defects.
World's Largest Resource for Cardiovascular Perfusion
We present the results obtained with the use of platelet-rich plasma and a hydroxyapatite and bovine collagen graft in the management of bone defects.
Dr. Mark Harris Yazer discusses the new electronic systems used to enhance recipient safety (35:11 minutes).
The state of undernutrition is an independent predictor of mortality in patients with AHF. Early recognition of undernutrition through use of the MNA may affect the long-term prognosis of these patients by enabling early intervention.